Worth Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Worth Asset Management's LLY Position: Q3 2026 in Review
Worth Asset Management increased its Eli Lilly (LLY) stake by 9.4% in Q3 2026, buying an estimated $181K and bringing the position to 1,786 shares worth $2.07M. The position accounts for 0.6% of the portfolio, ranked #38.
Worth Asset Management first reported a position in LLY in Q1 2022 and has held it in 19 quarters since. The position peaked at $2.9M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Worth Asset Management held 1,786 shares of Eli Lilly worth $2.07M as of Q3 2026.
- Worth Asset Management bought 153 Eli Lilly shares in Q3 2026, an estimated $181K.
- Eli Lilly made up 0.6% of Worth Asset Management's portfolio in Q3 2026, its #38 holding.
- Worth Asset Management first reported a position in Eli Lilly in Q1 2022 and has held it in 19 quarters since.
- Worth Asset Management's Eli Lilly position peaked at $2.9M in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Worth Asset Management's 13F filing for Q3 2026, filed 7 Oct 2026.